Daewoong Hosts Nabota Aesthetic Class in Buenos Aires

Daewoong Pharmaceutical organized the Nabota Master Class (NMC) LATAM 2026 in Buenos Aires, Argentina, from October 13 to 14, 2024. The two-day event aimed to enhance the completeness of aesthetic medicine for medical professionals from six Latin American countries: Brazil, Argentina, Chile, Ecuador, Peru, and Panama.

Invited speakers from South Korea, Brazil, Argentina, and the United Arab Emirates shared their clinical experiences and expertise, emphasizing the academic value of Nabota. Daewoong's Nabota, the first botulinum toxin made in South Korea to receive product approval in Argentina, has since been launched in 12 major Latin American countries.

The NMC focused on customized training to reflect the unique treatment environments and patient characteristics of medical professionals in Latin America. Beyond procedure-centered education, the event featured strengthened clinical approaches considering the anatomical characteristics and facial expression patterns of Latin patients.

Sessions included theoretical lectures on lifting and skin quality improvement strategies using NabOlift and NabOglow, as well as Nabota's differentiated procedure protocols. The program also covered various applications, such as functional anatomy for hyperhidrosis treatment and masseter procedures. In a live demonstration, compound procedure methods and actual injection techniques were showcased, including Glowtox, which combines botulinum toxin and skin boosters to enhance skin quality.

Medical professionals engaged in question-and-answer sessions to share knowledge applicable in clinical settings. Yoon Joon-soo, head of Daewoong Pharmaceutical's Nabota Business Division, highlighted the event's role in exploring the diverse potential uses of Nabota based on the accumulated expertise of medical professionals from each country. He also mentioned that the company would continue exchanges with medical professionals worldwide.